Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform
January 8, 2025
Coeptis Therapeutics Holdings, a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious diseases, is excited to announce the initial rollout